BlogZone Get the app

Finance

Revolution Medicines CEO Mark Goldsmith sells $2.78m in stock

Investing.com 18 Sept 2026 1 views

BlogZone shows headlines and summaries from public news feeds. The full story is published by Investing.com.

Read the full story at Investing.com →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Finance

Saba Capital sells $406,836 in PIMCO dynamic income strategy fund

Investing.com · 19 min ago

Neonc Technologies CEO Amir Heshmatpour buys $294.5K shares

Investing.com · 34 min ago

Saudi-led coalition intercepts missiles towards Riyadh, drones in Eastern Province

Investing.com · 38 min ago